Wall Street Analysts Boost Ratings on Top Stocks Today as AVAV Leads with Explosive Earnings

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  25 Jun 2025
 

•   AVAV  
   
  +12.79%

ANIX received a reiterated Buy rating from H.C. Wainwright, signaling continued confidence in Anixa Biosciences’ long-term potential. Despite a quiet trading session so far, the analyst backing reflects belief in the company’s biotech innovation pipeline and suggests future upside may be tied to clinical developments or strategic partnerships.

AVAV is drawing serious attention after crushing expectations with its Q4 earnings. AeroVironment delivered a massive beat driven by Loitering Munitions sales that far exceeded forecasts. Analysts reiterated their Buy rating, highlighting AVAV as a next-gen defense tech pure-play with strong momentum and a clear path for continued growth, especially in modern warfare systems and global defense contracts.

BABA saw Citi maintain its Buy rating, pointing to Alibaba’s long-term positioning within China’s tech ecosystem. Analysts continue to express confidence in its ability to recover from regulatory headwinds, supported by a leaner structure and growing emphasis on cloud and international commerce.

BKNG was upgraded on renewed optimism around the travel sector. Analysts were encouraged by improving performance across hospitality properties and believe Booking Holdings is poised to benefit from continued demand strength in global leisure and business travel.

CRDO earned a reiterated Buy rating from TD Cowen with a raised price target. Credo Technology continues to impress with its exposure to next-generation connectivity solutions and AI-driven infrastructure. The reaffirmation reflects analyst belief in its long-term growth prospects.

FDS received another Strong Buy rating as analysts signaled that its growth inflection is playing out as expected. FactSet continues to deliver steady results with a clear path for expansion through new data offerings and pricing leverage, keeping the bullish case intact.

FDX remains a Buy in analysts’ eyes despite withdrawing long-term guidance. Analysts pointed to a solid earnings beat and highlighted strength in the Freight segment as a sign of operational efficiency. The reaffirmed rating shows faith in FedEx’s ability to navigate macro uncertainty while delivering shareholder value.

HOMB was upgraded to Buy after recent underperformance, with analysts suggesting that the pullback created a more compelling valuation entry. The regional bank is now viewed as having a more attractive risk/reward profile going forward.

KBH was reiterated as a Buy even as full-year guidance was revised lower. Analysts acknowledged weaker-than-expected net orders but believe the valuation still supports a bullish stance, especially as the housing market shows pockets of strength and inventory tightness persists.

KHC was upgraded by Goldman Sachs from Sell to Neutral following the company’s announcement of a strategic review. The analyst shift indicates improving sentiment around Kraft Heinz’s ability to unlock value through potential asset sales or portfolio realignment.

NRG received a Strong Buy initiation from Raymond James, citing the company’s stable fundamentals and upside potential as energy transition tailwinds strengthen. Analysts see NRG as well-positioned for both growth and income-focused investors.

ORCL was upgraded by BMO after strong earnings and bullish guidance on its cloud business. Oracle’s continued transformation from legacy software to cloud infrastructure is gaining traction with analysts, who now see a more favorable growth narrative.

PD was reiterated as a Buy by Canaccord, despite a trimmed price target. Analysts remain optimistic about PagerDuty’s operational execution and positioning within the digital operations management space.

REGN was upgraded following a renewed look at valuation and pipeline progress. Regeneron is being reappraised as a strong biotech name with multiple long-term growth drivers, including its immunology and ophthalmology portfolios.

TEAM received a reaffirmed Buy rating from Mizuho, signaling continued confidence in Atlassian’s product roadmap and expansion within enterprise cloud. Analysts trimmed their price target but kept a bullish stance on the company’s fundamentals.

UBER continues to hold its Buy rating, with analysts bullish on its growth drivers across mobility, delivery, and logistics. The company’s steady expansion into new verticals and improved profitability are keeping sentiment constructive.

Bottom line: Of all the names upgraded or reiterated today $AVAV clearly leads with strong execution, a bullish earnings surprise, and powerful analyst support making it the top near-term opportunity for traders and investors alike.